Review




Structured Review

Shanghai GenePharma mpc1 sirna
Blocking <t>MPC1</t> impairs vascular endothelial function though disrupting energy homeostasis. Diagram of cell energy metabolism after blocking MPC1 using siRNA or UK-5099 (10 μM) ( A ); ( B–H ) RAECs was treated with UK-5099 for 24 h to block MPC1. Representative images of immunofluorescence analysis of eNOS ( B ); The protein expression of eNOS, p-eNOS, ZO-1, Claudin-5, Occludin and VE-Cadherin was detected. ∗ p < 0.05 (n = 4) ( C ); The protein expression of MCT4 in RAECs. ∗ p < 0.05 (n = 4) ( D ); Lactate content in the supernatant of RAECs culture. ∗ p < 0.05 (n = 3) ( E ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( F ); Representative images of the mitochondrial membrane potential of RAECs detected by JC-10, mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 8) ( G ); Representative TEM images of RAECs mitochondria, the arrows indicate mitochondria ( H ); ( I–O ) RAECs were transfected with MPC1 siRNA to knock down MPC1. Representative images of immunofluorescence analysis of eNOS in RAECs after knocking down MPC1 ( I ); The protein expression of eNOS, p-eNOS, ZO-1, Occludin and VE-Cadherin was detected. ∗∗∗ p < 0.001 (n = 4) ( J ); The protein and mRNA levels of MCT4 and MPC1 were detected. ∗∗ p < 0.01, ∗∗∗ p < 0.001 (n = 4) ( K ); Lactate content in the supernatant of RAECs culture. ∗∗ p < 0.01 (n = 3) ( L ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( M ); The oxygen consumption rate (OCR) of RAECs after MPC1 knockdown was analyzed by Seahorse XF analyzer, and the ATP production was normalized using intracellular protein content. ∗∗ p < 0.01 (n = 3) ( N ). Representative images of the mitochondrial membrane potential of RAECs detected by JC-10 after knocking down MPC1, and mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 7) ( O ).
Mpc1 Sirna, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpc1+sirnas/mpc1+sirnas/pmc12147897-55-7-27
Average 90 stars, based on 1 article reviews
mpc1 sirna - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "Hypobaric hypoxia-driven energy metabolism disturbance facilitates vascular endothelial dysfunction"

Article Title: Hypobaric hypoxia-driven energy metabolism disturbance facilitates vascular endothelial dysfunction

Journal: Redox Biology

doi: 10.1016/j.redox.2025.103675

Blocking MPC1 impairs vascular endothelial function though disrupting energy homeostasis. Diagram of cell energy metabolism after blocking MPC1 using siRNA or UK-5099 (10 μM) ( A ); ( B–H ) RAECs was treated with UK-5099 for 24 h to block MPC1. Representative images of immunofluorescence analysis of eNOS ( B ); The protein expression of eNOS, p-eNOS, ZO-1, Claudin-5, Occludin and VE-Cadherin was detected. ∗ p < 0.05 (n = 4) ( C ); The protein expression of MCT4 in RAECs. ∗ p < 0.05 (n = 4) ( D ); Lactate content in the supernatant of RAECs culture. ∗ p < 0.05 (n = 3) ( E ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( F ); Representative images of the mitochondrial membrane potential of RAECs detected by JC-10, mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 8) ( G ); Representative TEM images of RAECs mitochondria, the arrows indicate mitochondria ( H ); ( I–O ) RAECs were transfected with MPC1 siRNA to knock down MPC1. Representative images of immunofluorescence analysis of eNOS in RAECs after knocking down MPC1 ( I ); The protein expression of eNOS, p-eNOS, ZO-1, Occludin and VE-Cadherin was detected. ∗∗∗ p < 0.001 (n = 4) ( J ); The protein and mRNA levels of MCT4 and MPC1 were detected. ∗∗ p < 0.01, ∗∗∗ p < 0.001 (n = 4) ( K ); Lactate content in the supernatant of RAECs culture. ∗∗ p < 0.01 (n = 3) ( L ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( M ); The oxygen consumption rate (OCR) of RAECs after MPC1 knockdown was analyzed by Seahorse XF analyzer, and the ATP production was normalized using intracellular protein content. ∗∗ p < 0.01 (n = 3) ( N ). Representative images of the mitochondrial membrane potential of RAECs detected by JC-10 after knocking down MPC1, and mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 7) ( O ).
Figure Legend Snippet: Blocking MPC1 impairs vascular endothelial function though disrupting energy homeostasis. Diagram of cell energy metabolism after blocking MPC1 using siRNA or UK-5099 (10 μM) ( A ); ( B–H ) RAECs was treated with UK-5099 for 24 h to block MPC1. Representative images of immunofluorescence analysis of eNOS ( B ); The protein expression of eNOS, p-eNOS, ZO-1, Claudin-5, Occludin and VE-Cadherin was detected. ∗ p < 0.05 (n = 4) ( C ); The protein expression of MCT4 in RAECs. ∗ p < 0.05 (n = 4) ( D ); Lactate content in the supernatant of RAECs culture. ∗ p < 0.05 (n = 3) ( E ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( F ); Representative images of the mitochondrial membrane potential of RAECs detected by JC-10, mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 8) ( G ); Representative TEM images of RAECs mitochondria, the arrows indicate mitochondria ( H ); ( I–O ) RAECs were transfected with MPC1 siRNA to knock down MPC1. Representative images of immunofluorescence analysis of eNOS in RAECs after knocking down MPC1 ( I ); The protein expression of eNOS, p-eNOS, ZO-1, Occludin and VE-Cadherin was detected. ∗∗∗ p < 0.001 (n = 4) ( J ); The protein and mRNA levels of MCT4 and MPC1 were detected. ∗∗ p < 0.01, ∗∗∗ p < 0.001 (n = 4) ( K ); Lactate content in the supernatant of RAECs culture. ∗∗ p < 0.01 (n = 3) ( L ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( M ); The oxygen consumption rate (OCR) of RAECs after MPC1 knockdown was analyzed by Seahorse XF analyzer, and the ATP production was normalized using intracellular protein content. ∗∗ p < 0.01 (n = 3) ( N ). Representative images of the mitochondrial membrane potential of RAECs detected by JC-10 after knocking down MPC1, and mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 7) ( O ).

Techniques Used: Blocking Assay, Immunofluorescence, Expressing, Membrane, Fluorescence, Transfection, Knockdown

Related Articles

Synthesized:

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway
Article Snippet: Cell transfection was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). .. The siRNAs were list as follows, MPC1 siRNAs were custom synthesized from GenePharma (Shanghai, China) and were pooled as (5′-UCCCTCTUTTUCTATTCTTTU-3′) and (5′-UUCTTATCAAACACUAUATUA-3′). ..



Similar Products

90
Shanghai GenePharma mpc1 sirna
Blocking <t>MPC1</t> impairs vascular endothelial function though disrupting energy homeostasis. Diagram of cell energy metabolism after blocking MPC1 using siRNA or UK-5099 (10 μM) ( A ); ( B–H ) RAECs was treated with UK-5099 for 24 h to block MPC1. Representative images of immunofluorescence analysis of eNOS ( B ); The protein expression of eNOS, p-eNOS, ZO-1, Claudin-5, Occludin and VE-Cadherin was detected. ∗ p < 0.05 (n = 4) ( C ); The protein expression of MCT4 in RAECs. ∗ p < 0.05 (n = 4) ( D ); Lactate content in the supernatant of RAECs culture. ∗ p < 0.05 (n = 3) ( E ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( F ); Representative images of the mitochondrial membrane potential of RAECs detected by JC-10, mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 8) ( G ); Representative TEM images of RAECs mitochondria, the arrows indicate mitochondria ( H ); ( I–O ) RAECs were transfected with MPC1 siRNA to knock down MPC1. Representative images of immunofluorescence analysis of eNOS in RAECs after knocking down MPC1 ( I ); The protein expression of eNOS, p-eNOS, ZO-1, Occludin and VE-Cadherin was detected. ∗∗∗ p < 0.001 (n = 4) ( J ); The protein and mRNA levels of MCT4 and MPC1 were detected. ∗∗ p < 0.01, ∗∗∗ p < 0.001 (n = 4) ( K ); Lactate content in the supernatant of RAECs culture. ∗∗ p < 0.01 (n = 3) ( L ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( M ); The oxygen consumption rate (OCR) of RAECs after MPC1 knockdown was analyzed by Seahorse XF analyzer, and the ATP production was normalized using intracellular protein content. ∗∗ p < 0.01 (n = 3) ( N ). Representative images of the mitochondrial membrane potential of RAECs detected by JC-10 after knocking down MPC1, and mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 7) ( O ).
Mpc1 Sirna, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpc1+sirnas/mpc1+sirnas/pmc12147897-55-7-27
Average 90 stars, based on 1 article reviews
mpc1 sirna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma mpc1 sirnas
a Western blotting showing the expression of <t>MPC1</t> in nine pairs LAC tumor tissue (T) and adjacent normal tissues (N). b Quantitative analysis of MPC1 protein expression in nine pairs LAC tumor tissue and adjacent normal tissues. c Expression of MPC1 mRNA in 15 pairs of LAC tumor tissues and adjacent normal tissues. d qRT-PCR and western blotting showing the expression of MPC1 in LAC cells (A549, H1299, H1975) and normal human bronchial epithelial cells (HBE). e Representative IHC image for LAC patients with MPC1 low and MPC1 high , Scare bar = 50 μm. f Kaplan–Meier analysis of overall survival rate (OS) in LAC patients with MPC1 low and MPC1 high . g Kaplan–Meier analyses of MPC1 in LAC patients from GEO database ( n = 1926). Data are expressed as the mean ± SD,* P <0.05, *** P <0.001
Mpc1 Sirnas, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpc1+sirnas/mpc1+sirnas/pmc06377639-43-6-12
Average 90 stars, based on 1 article reviews
mpc1 sirnas - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma sirnas targeting mpc1
a Western blotting showing the expression of <t>MPC1</t> in nine pairs LAC tumor tissue (T) and adjacent normal tissues (N). b Quantitative analysis of MPC1 protein expression in nine pairs LAC tumor tissue and adjacent normal tissues. c Expression of MPC1 mRNA in 15 pairs of LAC tumor tissues and adjacent normal tissues. d qRT-PCR and western blotting showing the expression of MPC1 in LAC cells (A549, H1299, H1975) and normal human bronchial epithelial cells (HBE). e Representative IHC image for LAC patients with MPC1 low and MPC1 high , Scare bar = 50 μm. f Kaplan–Meier analysis of overall survival rate (OS) in LAC patients with MPC1 low and MPC1 high . g Kaplan–Meier analyses of MPC1 in LAC patients from GEO database ( n = 1926). Data are expressed as the mean ± SD,* P <0.05, *** P <0.001
Sirnas Targeting Mpc1, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpc1+sirnas/mpc1+sirnas/pmc06377639-41-16-19
Average 90 stars, based on 1 article reviews
sirnas targeting mpc1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Thermo Fisher mpc1 small interfering (sirna) oligonucleotide (simpc1) and a scrambled oligonucleotide
a Western blotting showing the expression of <t>MPC1</t> in nine pairs LAC tumor tissue (T) and adjacent normal tissues (N). b Quantitative analysis of MPC1 protein expression in nine pairs LAC tumor tissue and adjacent normal tissues. c Expression of MPC1 mRNA in 15 pairs of LAC tumor tissues and adjacent normal tissues. d qRT-PCR and western blotting showing the expression of MPC1 in LAC cells (A549, H1299, H1975) and normal human bronchial epithelial cells (HBE). e Representative IHC image for LAC patients with MPC1 low and MPC1 high , Scare bar = 50 μm. f Kaplan–Meier analysis of overall survival rate (OS) in LAC patients with MPC1 low and MPC1 high . g Kaplan–Meier analyses of MPC1 in LAC patients from GEO database ( n = 1926). Data are expressed as the mean ± SD,* P <0.05, *** P <0.001
Mpc1 Small Interfering (Sirna) Oligonucleotide (Simpc1) And A Scrambled Oligonucleotide, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpc1+sirnas/magnetic+particle+concentrator/pm29286150-56-9-13
Average 90 stars, based on 1 article reviews
mpc1 small interfering (sirna) oligonucleotide (simpc1) and a scrambled oligonucleotide - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Blocking MPC1 impairs vascular endothelial function though disrupting energy homeostasis. Diagram of cell energy metabolism after blocking MPC1 using siRNA or UK-5099 (10 μM) ( A ); ( B–H ) RAECs was treated with UK-5099 for 24 h to block MPC1. Representative images of immunofluorescence analysis of eNOS ( B ); The protein expression of eNOS, p-eNOS, ZO-1, Claudin-5, Occludin and VE-Cadherin was detected. ∗ p < 0.05 (n = 4) ( C ); The protein expression of MCT4 in RAECs. ∗ p < 0.05 (n = 4) ( D ); Lactate content in the supernatant of RAECs culture. ∗ p < 0.05 (n = 3) ( E ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( F ); Representative images of the mitochondrial membrane potential of RAECs detected by JC-10, mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 8) ( G ); Representative TEM images of RAECs mitochondria, the arrows indicate mitochondria ( H ); ( I–O ) RAECs were transfected with MPC1 siRNA to knock down MPC1. Representative images of immunofluorescence analysis of eNOS in RAECs after knocking down MPC1 ( I ); The protein expression of eNOS, p-eNOS, ZO-1, Occludin and VE-Cadherin was detected. ∗∗∗ p < 0.001 (n = 4) ( J ); The protein and mRNA levels of MCT4 and MPC1 were detected. ∗∗ p < 0.01, ∗∗∗ p < 0.001 (n = 4) ( K ); Lactate content in the supernatant of RAECs culture. ∗∗ p < 0.01 (n = 3) ( L ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( M ); The oxygen consumption rate (OCR) of RAECs after MPC1 knockdown was analyzed by Seahorse XF analyzer, and the ATP production was normalized using intracellular protein content. ∗∗ p < 0.01 (n = 3) ( N ). Representative images of the mitochondrial membrane potential of RAECs detected by JC-10 after knocking down MPC1, and mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 7) ( O ).

Journal: Redox Biology

Article Title: Hypobaric hypoxia-driven energy metabolism disturbance facilitates vascular endothelial dysfunction

doi: 10.1016/j.redox.2025.103675

Figure Lengend Snippet: Blocking MPC1 impairs vascular endothelial function though disrupting energy homeostasis. Diagram of cell energy metabolism after blocking MPC1 using siRNA or UK-5099 (10 μM) ( A ); ( B–H ) RAECs was treated with UK-5099 for 24 h to block MPC1. Representative images of immunofluorescence analysis of eNOS ( B ); The protein expression of eNOS, p-eNOS, ZO-1, Claudin-5, Occludin and VE-Cadherin was detected. ∗ p < 0.05 (n = 4) ( C ); The protein expression of MCT4 in RAECs. ∗ p < 0.05 (n = 4) ( D ); Lactate content in the supernatant of RAECs culture. ∗ p < 0.05 (n = 3) ( E ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( F ); Representative images of the mitochondrial membrane potential of RAECs detected by JC-10, mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 8) ( G ); Representative TEM images of RAECs mitochondria, the arrows indicate mitochondria ( H ); ( I–O ) RAECs were transfected with MPC1 siRNA to knock down MPC1. Representative images of immunofluorescence analysis of eNOS in RAECs after knocking down MPC1 ( I ); The protein expression of eNOS, p-eNOS, ZO-1, Occludin and VE-Cadherin was detected. ∗∗∗ p < 0.001 (n = 4) ( J ); The protein and mRNA levels of MCT4 and MPC1 were detected. ∗∗ p < 0.01, ∗∗∗ p < 0.001 (n = 4) ( K ); Lactate content in the supernatant of RAECs culture. ∗∗ p < 0.01 (n = 3) ( L ); Lactate content in the cytosol of RAECs, normalized using intracellular protein content. ∗ p < 0.05 (n = 3) ( M ); The oxygen consumption rate (OCR) of RAECs after MPC1 knockdown was analyzed by Seahorse XF analyzer, and the ATP production was normalized using intracellular protein content. ∗∗ p < 0.01 (n = 3) ( N ). Representative images of the mitochondrial membrane potential of RAECs detected by JC-10 after knocking down MPC1, and mitochondrial membrane potential was quantified by red-green fluorescence ratio. ∗∗∗ p < 0.001 (n = 7) ( O ).

Article Snippet: Mouse MCT4 (sense: CACGGCAGGUUUCAUAACATT, antisense: UGUUA UGAAACCUGCCGUGTT), MPC1 (sense: GCUAUUCUCUGACAUUCAUTT, antisense: AUGAAUGUCAGAGAAUAGCTT), PKM2 (sense: GCCACAGAAA GCUUUGCAUTT, antisense: AUGCAAAGCUUUCUGUGGCTT) and control small interfering RNA (siRNA) were obtained from GenePharma (Shanghai, China).

Techniques: Blocking Assay, Immunofluorescence, Expressing, Membrane, Fluorescence, Transfection, Knockdown

a Western blotting showing the expression of MPC1 in nine pairs LAC tumor tissue (T) and adjacent normal tissues (N). b Quantitative analysis of MPC1 protein expression in nine pairs LAC tumor tissue and adjacent normal tissues. c Expression of MPC1 mRNA in 15 pairs of LAC tumor tissues and adjacent normal tissues. d qRT-PCR and western blotting showing the expression of MPC1 in LAC cells (A549, H1299, H1975) and normal human bronchial epithelial cells (HBE). e Representative IHC image for LAC patients with MPC1 low and MPC1 high , Scare bar = 50 μm. f Kaplan–Meier analysis of overall survival rate (OS) in LAC patients with MPC1 low and MPC1 high . g Kaplan–Meier analyses of MPC1 in LAC patients from GEO database ( n = 1926). Data are expressed as the mean ± SD,* P <0.05, *** P <0.001

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a Western blotting showing the expression of MPC1 in nine pairs LAC tumor tissue (T) and adjacent normal tissues (N). b Quantitative analysis of MPC1 protein expression in nine pairs LAC tumor tissue and adjacent normal tissues. c Expression of MPC1 mRNA in 15 pairs of LAC tumor tissues and adjacent normal tissues. d qRT-PCR and western blotting showing the expression of MPC1 in LAC cells (A549, H1299, H1975) and normal human bronchial epithelial cells (HBE). e Representative IHC image for LAC patients with MPC1 low and MPC1 high , Scare bar = 50 μm. f Kaplan–Meier analysis of overall survival rate (OS) in LAC patients with MPC1 low and MPC1 high . g Kaplan–Meier analyses of MPC1 in LAC patients from GEO database ( n = 1926). Data are expressed as the mean ± SD,* P <0.05, *** P <0.001

Article Snippet: The siRNAs were list as follows, MPC1 siRNAs were custom synthesized from GenePharma (Shanghai, China) and were pooled as (5′-UCCCTCTUTTUCTATTCTTTU-3′) and (5′-UUCTTATCAAACACUAUATUA-3′).

Techniques: Western Blot, Expressing, Quantitative RT-PCR

Univariate and multivariate analysis for overall survival in LAC patients

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: Univariate and multivariate analysis for overall survival in LAC patients

Article Snippet: The siRNAs were list as follows, MPC1 siRNAs were custom synthesized from GenePharma (Shanghai, China) and were pooled as (5′-UCCCTCTUTTUCTATTCTTTU-3′) and (5′-UUCTTATCAAACACUAUATUA-3′).

Techniques: Significance Assay, Expressing

a , b The representative images ( a ) and numbers ( b ) of tumorsphere in OE MPC1 cells and Ctrl cells by tumorsphere formation assay, scale bar = 100 µm. c , d The representative images ( c ) and numbers ( d ) of tumorsphere in si MPC1 and siNC LAC cells, and cells treated with DMSO or UK5099 (40 μM) by tumorsphere formation assay, scale bar = 100 µm. e , f Western blotting analysis of the abundances of NANOG, OCT4, and SOX2 in up- ( e ) and downregulated ( f ) MPC1 groups as compared with control groups. Data are expressed as the mean ± SD, ** P <0.01

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a , b The representative images ( a ) and numbers ( b ) of tumorsphere in OE MPC1 cells and Ctrl cells by tumorsphere formation assay, scale bar = 100 µm. c , d The representative images ( c ) and numbers ( d ) of tumorsphere in si MPC1 and siNC LAC cells, and cells treated with DMSO or UK5099 (40 μM) by tumorsphere formation assay, scale bar = 100 µm. e , f Western blotting analysis of the abundances of NANOG, OCT4, and SOX2 in up- ( e ) and downregulated ( f ) MPC1 groups as compared with control groups. Data are expressed as the mean ± SD, ** P <0.01

Article Snippet: The siRNAs were list as follows, MPC1 siRNAs were custom synthesized from GenePharma (Shanghai, China) and were pooled as (5′-UCCCTCTUTTUCTATTCTTTU-3′) and (5′-UUCTTATCAAACACUAUATUA-3′).

Techniques: Tube Formation Assay, Western Blot, Control

a , b The representative images ( a ) and numbers ( b ) of motile OE MPC1 cells and Ctrl cells in the transwell invasion and migration assay (scale bar = 50 µm). c , d The representative images ( c ) and numbers ( d ) of motile siNC, si MPC1 in H1299 cells; DMSO- and UK5099-H1299 cells in the transwell invasion and migration assay (scale bar = 50 µm). e , f Immunofluorescence showing the representative images ( e ) and numbers ( f ) of invadopodia with OE MPC1 or Ctrl, the nuclei were stained with DAPI (blue) (Scale bar = 20 µm). g , h Immunofluorescence showing the representative images ( g ) and numbers ( h ) of invadopodia with si MPC1 or siNC, the nuclei were stained with DAPI (blue) (scale bar = 20 µm), Data are expressed as the mean ± SD, * P <0.05, ** P <0.01, *** P <0.001

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a , b The representative images ( a ) and numbers ( b ) of motile OE MPC1 cells and Ctrl cells in the transwell invasion and migration assay (scale bar = 50 µm). c , d The representative images ( c ) and numbers ( d ) of motile siNC, si MPC1 in H1299 cells; DMSO- and UK5099-H1299 cells in the transwell invasion and migration assay (scale bar = 50 µm). e , f Immunofluorescence showing the representative images ( e ) and numbers ( f ) of invadopodia with OE MPC1 or Ctrl, the nuclei were stained with DAPI (blue) (Scale bar = 20 µm). g , h Immunofluorescence showing the representative images ( g ) and numbers ( h ) of invadopodia with si MPC1 or siNC, the nuclei were stained with DAPI (blue) (scale bar = 20 µm), Data are expressed as the mean ± SD, * P <0.05, ** P <0.01, *** P <0.001

Article Snippet: The siRNAs were list as follows, MPC1 siRNAs were custom synthesized from GenePharma (Shanghai, China) and were pooled as (5′-UCCCTCTUTTUCTATTCTTTU-3′) and (5′-UUCTTATCAAACACUAUATUA-3′).

Techniques: Migration, Immunofluorescence, Staining

a Identification of STAT3 from the intersection between MPC1 interacting protein set by MS and the KEGG pathway in cancer gene set from GSEA. b , c Co-IP analysis of STAT3 interaction with MPC1 in A549 and H1299 MPC1-overpxpression cells. d The mitochondria was isolated from the cytoplasm, and Co-IP analysis showing that STAT3 interacts with MPC1 in the mitochondria in A549 and H1299 MPC1-overpxpression cells. e Western blotting showing that the protein expression levels of STAT3, P-STAT3(S727), P-STAT3(Y705), and MPC1 in A549 and H1299 cell with stable infection of OE MPC1 or Ctrl vector. f The mitochondria was isolated from the cytoplasm, mitochondria (mito) and cytoplasm without mitochondria (cyto) were prepared, western blotting showing that the protein expression levels of P-STAT3(Y705), STAT3, MPC1, and mitochondrial reference COX IV in A549 and H1299 cell with stable infection of OE MPC1 or Ctrl vector. g The nuclear and cytoplasmic extracts were prepared. Western blotting showing that overexpression of MPC1 decreased the expression of P-STAT3(Y705) in the nuclei. h IHC showing the expression of P-STAT3(Y705) in the MPC1 low LAC tissues ( n = 11) and MPC1 high ( n = 9) LAC tissues, Scale bar = 50 μm. i IHC score of P-STAT3(Y705) in the MPC1 low LAC tissues ( n = 11) and MPC1 high LAC tissues ( n = 9). Data are expressed as the mean ± SD, * P <0.05

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a Identification of STAT3 from the intersection between MPC1 interacting protein set by MS and the KEGG pathway in cancer gene set from GSEA. b , c Co-IP analysis of STAT3 interaction with MPC1 in A549 and H1299 MPC1-overpxpression cells. d The mitochondria was isolated from the cytoplasm, and Co-IP analysis showing that STAT3 interacts with MPC1 in the mitochondria in A549 and H1299 MPC1-overpxpression cells. e Western blotting showing that the protein expression levels of STAT3, P-STAT3(S727), P-STAT3(Y705), and MPC1 in A549 and H1299 cell with stable infection of OE MPC1 or Ctrl vector. f The mitochondria was isolated from the cytoplasm, mitochondria (mito) and cytoplasm without mitochondria (cyto) were prepared, western blotting showing that the protein expression levels of P-STAT3(Y705), STAT3, MPC1, and mitochondrial reference COX IV in A549 and H1299 cell with stable infection of OE MPC1 or Ctrl vector. g The nuclear and cytoplasmic extracts were prepared. Western blotting showing that overexpression of MPC1 decreased the expression of P-STAT3(Y705) in the nuclei. h IHC showing the expression of P-STAT3(Y705) in the MPC1 low LAC tissues ( n = 11) and MPC1 high ( n = 9) LAC tissues, Scale bar = 50 μm. i IHC score of P-STAT3(Y705) in the MPC1 low LAC tissues ( n = 11) and MPC1 high LAC tissues ( n = 9). Data are expressed as the mean ± SD, * P <0.05

Article Snippet: The siRNAs were list as follows, MPC1 siRNAs were custom synthesized from GenePharma (Shanghai, China) and were pooled as (5′-UCCCTCTUTTUCTATTCTTTU-3′) and (5′-UUCTTATCAAACACUAUATUA-3′).

Techniques: Co-Immunoprecipitation Assay, Isolation, Western Blot, Expressing, Infection, Plasmid Preparation, Over Expression

a Western blotting showing the protein expression levels of STAT3 and P-STAT3(Y705) in A549 cells treated with IL-6 for 24 h at the indicated dose. b , c The representative images ( b ) and numbers ( c ) of tumorspheres from the Ctrl and OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). Scale bar = 100 µm. d The number of motile Ctrl and OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). e Western blotting showing the expression of SOX2, MMP2, and MPC1 in Ctrl or OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). Data are expressed as the mean ± SD, * P <0.05, ** P <0.01

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a Western blotting showing the protein expression levels of STAT3 and P-STAT3(Y705) in A549 cells treated with IL-6 for 24 h at the indicated dose. b , c The representative images ( b ) and numbers ( c ) of tumorspheres from the Ctrl and OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). Scale bar = 100 µm. d The number of motile Ctrl and OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). e Western blotting showing the expression of SOX2, MMP2, and MPC1 in Ctrl or OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). Data are expressed as the mean ± SD, * P <0.05, ** P <0.01

Article Snippet: The siRNAs were list as follows, MPC1 siRNAs were custom synthesized from GenePharma (Shanghai, China) and were pooled as (5′-UCCCTCTUTTUCTATTCTTTU-3′) and (5′-UUCTTATCAAACACUAUATUA-3′).

Techniques: Western Blot, Expressing

a Nude mice were injected subcutaneously in the right flanks with Ctrl or MPC1-overexpression A549 cells. After 28 days, xenografts were harvested and photographed. b , c Quantitative analysis of the volume ( b ) and weight ( c ) of the xenograft tumors. d IHC staining showing the expression of MPC1, P-STAT3(Y705), SOX2, and MMP2 in the xenograft tumors derived from OE MPC1 and Ctrl cells, Scale bar = 25 µm. e Schematic diagram of the regulatory mechanism of MPC1 mediates STAT3 dephosphorylation and inhibits the stemness and invasion of LAC cells. Data are expressed as the mean ± SD,* P <0.05, ** P <0.01, *** P <0.001

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a Nude mice were injected subcutaneously in the right flanks with Ctrl or MPC1-overexpression A549 cells. After 28 days, xenografts were harvested and photographed. b , c Quantitative analysis of the volume ( b ) and weight ( c ) of the xenograft tumors. d IHC staining showing the expression of MPC1, P-STAT3(Y705), SOX2, and MMP2 in the xenograft tumors derived from OE MPC1 and Ctrl cells, Scale bar = 25 µm. e Schematic diagram of the regulatory mechanism of MPC1 mediates STAT3 dephosphorylation and inhibits the stemness and invasion of LAC cells. Data are expressed as the mean ± SD,* P <0.05, ** P <0.01, *** P <0.001

Article Snippet: The siRNAs were list as follows, MPC1 siRNAs were custom synthesized from GenePharma (Shanghai, China) and were pooled as (5′-UCCCTCTUTTUCTATTCTTTU-3′) and (5′-UUCTTATCAAACACUAUATUA-3′).

Techniques: Injection, Over Expression, Immunohistochemistry, Expressing, Derivative Assay, De-Phosphorylation Assay

a Western blotting showing the expression of MPC1 in nine pairs LAC tumor tissue (T) and adjacent normal tissues (N). b Quantitative analysis of MPC1 protein expression in nine pairs LAC tumor tissue and adjacent normal tissues. c Expression of MPC1 mRNA in 15 pairs of LAC tumor tissues and adjacent normal tissues. d qRT-PCR and western blotting showing the expression of MPC1 in LAC cells (A549, H1299, H1975) and normal human bronchial epithelial cells (HBE). e Representative IHC image for LAC patients with MPC1 low and MPC1 high , Scare bar = 50 μm. f Kaplan–Meier analysis of overall survival rate (OS) in LAC patients with MPC1 low and MPC1 high . g Kaplan–Meier analyses of MPC1 in LAC patients from GEO database ( n = 1926). Data are expressed as the mean ± SD,* P <0.05, *** P <0.001

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a Western blotting showing the expression of MPC1 in nine pairs LAC tumor tissue (T) and adjacent normal tissues (N). b Quantitative analysis of MPC1 protein expression in nine pairs LAC tumor tissue and adjacent normal tissues. c Expression of MPC1 mRNA in 15 pairs of LAC tumor tissues and adjacent normal tissues. d qRT-PCR and western blotting showing the expression of MPC1 in LAC cells (A549, H1299, H1975) and normal human bronchial epithelial cells (HBE). e Representative IHC image for LAC patients with MPC1 low and MPC1 high , Scare bar = 50 μm. f Kaplan–Meier analysis of overall survival rate (OS) in LAC patients with MPC1 low and MPC1 high . g Kaplan–Meier analyses of MPC1 in LAC patients from GEO database ( n = 1926). Data are expressed as the mean ± SD,* P <0.05, *** P <0.001

Article Snippet: For the si MPC1 cell line, H1299 cells (1 × 10 6 /well) were infected with siRNAs targeting MPC1 (GenePharma, Shanghai, China).

Techniques: Western Blot, Expressing, Quantitative RT-PCR

Univariate and multivariate analysis for overall survival in LAC patients

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: Univariate and multivariate analysis for overall survival in LAC patients

Article Snippet: For the si MPC1 cell line, H1299 cells (1 × 10 6 /well) were infected with siRNAs targeting MPC1 (GenePharma, Shanghai, China).

Techniques: Significance Assay, Expressing

a , b The representative images ( a ) and numbers ( b ) of tumorsphere in OE MPC1 cells and Ctrl cells by tumorsphere formation assay, scale bar = 100 µm. c , d The representative images ( c ) and numbers ( d ) of tumorsphere in si MPC1 and siNC LAC cells, and cells treated with DMSO or UK5099 (40 μM) by tumorsphere formation assay, scale bar = 100 µm. e , f Western blotting analysis of the abundances of NANOG, OCT4, and SOX2 in up- ( e ) and downregulated ( f ) MPC1 groups as compared with control groups. Data are expressed as the mean ± SD, ** P <0.01

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a , b The representative images ( a ) and numbers ( b ) of tumorsphere in OE MPC1 cells and Ctrl cells by tumorsphere formation assay, scale bar = 100 µm. c , d The representative images ( c ) and numbers ( d ) of tumorsphere in si MPC1 and siNC LAC cells, and cells treated with DMSO or UK5099 (40 μM) by tumorsphere formation assay, scale bar = 100 µm. e , f Western blotting analysis of the abundances of NANOG, OCT4, and SOX2 in up- ( e ) and downregulated ( f ) MPC1 groups as compared with control groups. Data are expressed as the mean ± SD, ** P <0.01

Article Snippet: For the si MPC1 cell line, H1299 cells (1 × 10 6 /well) were infected with siRNAs targeting MPC1 (GenePharma, Shanghai, China).

Techniques: Tube Formation Assay, Western Blot, Control

a , b The representative images ( a ) and numbers ( b ) of motile OE MPC1 cells and Ctrl cells in the transwell invasion and migration assay (scale bar = 50 µm). c , d The representative images ( c ) and numbers ( d ) of motile siNC, si MPC1 in H1299 cells; DMSO- and UK5099-H1299 cells in the transwell invasion and migration assay (scale bar = 50 µm). e , f Immunofluorescence showing the representative images ( e ) and numbers ( f ) of invadopodia with OE MPC1 or Ctrl, the nuclei were stained with DAPI (blue) (Scale bar = 20 µm). g , h Immunofluorescence showing the representative images ( g ) and numbers ( h ) of invadopodia with si MPC1 or siNC, the nuclei were stained with DAPI (blue) (scale bar = 20 µm), Data are expressed as the mean ± SD, * P <0.05, ** P <0.01, *** P <0.001

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a , b The representative images ( a ) and numbers ( b ) of motile OE MPC1 cells and Ctrl cells in the transwell invasion and migration assay (scale bar = 50 µm). c , d The representative images ( c ) and numbers ( d ) of motile siNC, si MPC1 in H1299 cells; DMSO- and UK5099-H1299 cells in the transwell invasion and migration assay (scale bar = 50 µm). e , f Immunofluorescence showing the representative images ( e ) and numbers ( f ) of invadopodia with OE MPC1 or Ctrl, the nuclei were stained with DAPI (blue) (Scale bar = 20 µm). g , h Immunofluorescence showing the representative images ( g ) and numbers ( h ) of invadopodia with si MPC1 or siNC, the nuclei were stained with DAPI (blue) (scale bar = 20 µm), Data are expressed as the mean ± SD, * P <0.05, ** P <0.01, *** P <0.001

Article Snippet: For the si MPC1 cell line, H1299 cells (1 × 10 6 /well) were infected with siRNAs targeting MPC1 (GenePharma, Shanghai, China).

Techniques: Migration, Immunofluorescence, Staining

a Identification of STAT3 from the intersection between MPC1 interacting protein set by MS and the KEGG pathway in cancer gene set from GSEA. b , c Co-IP analysis of STAT3 interaction with MPC1 in A549 and H1299 MPC1-overpxpression cells. d The mitochondria was isolated from the cytoplasm, and Co-IP analysis showing that STAT3 interacts with MPC1 in the mitochondria in A549 and H1299 MPC1-overpxpression cells. e Western blotting showing that the protein expression levels of STAT3, P-STAT3(S727), P-STAT3(Y705), and MPC1 in A549 and H1299 cell with stable infection of OE MPC1 or Ctrl vector. f The mitochondria was isolated from the cytoplasm, mitochondria (mito) and cytoplasm without mitochondria (cyto) were prepared, western blotting showing that the protein expression levels of P-STAT3(Y705), STAT3, MPC1, and mitochondrial reference COX IV in A549 and H1299 cell with stable infection of OE MPC1 or Ctrl vector. g The nuclear and cytoplasmic extracts were prepared. Western blotting showing that overexpression of MPC1 decreased the expression of P-STAT3(Y705) in the nuclei. h IHC showing the expression of P-STAT3(Y705) in the MPC1 low LAC tissues ( n = 11) and MPC1 high ( n = 9) LAC tissues, Scale bar = 50 μm. i IHC score of P-STAT3(Y705) in the MPC1 low LAC tissues ( n = 11) and MPC1 high LAC tissues ( n = 9). Data are expressed as the mean ± SD, * P <0.05

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a Identification of STAT3 from the intersection between MPC1 interacting protein set by MS and the KEGG pathway in cancer gene set from GSEA. b , c Co-IP analysis of STAT3 interaction with MPC1 in A549 and H1299 MPC1-overpxpression cells. d The mitochondria was isolated from the cytoplasm, and Co-IP analysis showing that STAT3 interacts with MPC1 in the mitochondria in A549 and H1299 MPC1-overpxpression cells. e Western blotting showing that the protein expression levels of STAT3, P-STAT3(S727), P-STAT3(Y705), and MPC1 in A549 and H1299 cell with stable infection of OE MPC1 or Ctrl vector. f The mitochondria was isolated from the cytoplasm, mitochondria (mito) and cytoplasm without mitochondria (cyto) were prepared, western blotting showing that the protein expression levels of P-STAT3(Y705), STAT3, MPC1, and mitochondrial reference COX IV in A549 and H1299 cell with stable infection of OE MPC1 or Ctrl vector. g The nuclear and cytoplasmic extracts were prepared. Western blotting showing that overexpression of MPC1 decreased the expression of P-STAT3(Y705) in the nuclei. h IHC showing the expression of P-STAT3(Y705) in the MPC1 low LAC tissues ( n = 11) and MPC1 high ( n = 9) LAC tissues, Scale bar = 50 μm. i IHC score of P-STAT3(Y705) in the MPC1 low LAC tissues ( n = 11) and MPC1 high LAC tissues ( n = 9). Data are expressed as the mean ± SD, * P <0.05

Article Snippet: For the si MPC1 cell line, H1299 cells (1 × 10 6 /well) were infected with siRNAs targeting MPC1 (GenePharma, Shanghai, China).

Techniques: Co-Immunoprecipitation Assay, Isolation, Western Blot, Expressing, Infection, Plasmid Preparation, Over Expression

a Western blotting showing the protein expression levels of STAT3 and P-STAT3(Y705) in A549 cells treated with IL-6 for 24 h at the indicated dose. b , c The representative images ( b ) and numbers ( c ) of tumorspheres from the Ctrl and OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). Scale bar = 100 µm. d The number of motile Ctrl and OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). e Western blotting showing the expression of SOX2, MMP2, and MPC1 in Ctrl or OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). Data are expressed as the mean ± SD, * P <0.05, ** P <0.01

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a Western blotting showing the protein expression levels of STAT3 and P-STAT3(Y705) in A549 cells treated with IL-6 for 24 h at the indicated dose. b , c The representative images ( b ) and numbers ( c ) of tumorspheres from the Ctrl and OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). Scale bar = 100 µm. d The number of motile Ctrl and OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). e Western blotting showing the expression of SOX2, MMP2, and MPC1 in Ctrl or OE MPC1 A549 and H1299 cells treated with or without IL-6 (100 ng/ml). Data are expressed as the mean ± SD, * P <0.05, ** P <0.01

Article Snippet: For the si MPC1 cell line, H1299 cells (1 × 10 6 /well) were infected with siRNAs targeting MPC1 (GenePharma, Shanghai, China).

Techniques: Western Blot, Expressing

a Nude mice were injected subcutaneously in the right flanks with Ctrl or MPC1-overexpression A549 cells. After 28 days, xenografts were harvested and photographed. b , c Quantitative analysis of the volume ( b ) and weight ( c ) of the xenograft tumors. d IHC staining showing the expression of MPC1, P-STAT3(Y705), SOX2, and MMP2 in the xenograft tumors derived from OE MPC1 and Ctrl cells, Scale bar = 25 µm. e Schematic diagram of the regulatory mechanism of MPC1 mediates STAT3 dephosphorylation and inhibits the stemness and invasion of LAC cells. Data are expressed as the mean ± SD,* P <0.05, ** P <0.01, *** P <0.001

Journal: Cell Death & Disease

Article Title: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

doi: 10.1038/s41419-019-1324-8

Figure Lengend Snippet: a Nude mice were injected subcutaneously in the right flanks with Ctrl or MPC1-overexpression A549 cells. After 28 days, xenografts were harvested and photographed. b , c Quantitative analysis of the volume ( b ) and weight ( c ) of the xenograft tumors. d IHC staining showing the expression of MPC1, P-STAT3(Y705), SOX2, and MMP2 in the xenograft tumors derived from OE MPC1 and Ctrl cells, Scale bar = 25 µm. e Schematic diagram of the regulatory mechanism of MPC1 mediates STAT3 dephosphorylation and inhibits the stemness and invasion of LAC cells. Data are expressed as the mean ± SD,* P <0.05, ** P <0.01, *** P <0.001

Article Snippet: For the si MPC1 cell line, H1299 cells (1 × 10 6 /well) were infected with siRNAs targeting MPC1 (GenePharma, Shanghai, China).

Techniques: Injection, Over Expression, Immunohistochemistry, Expressing, Derivative Assay, De-Phosphorylation Assay